Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 16/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26157410 | 1.00 | HRH3 (0.56) | HRH3KDM4ERECQLTDP1ALDH1A1 | |
| SCHEMBL20234910 | 1.00 | HRH3 (0.56) | HRH3KDM4ERECQLTDP1ALDH1A1 | |
| SCHEMBL26157409 | 1.00 | HRH3 (0.56) | HRH3KDM4ERECQLTDP1ALDH1A1 | |
| SCHEMBL26157397 | 1.00 | HRH3 (0.56) | HRH3KDM4ERECQLTDP1ALDH1A1 | |
| SCHEMBL26157401 | 1.00 | HRH3 (0.56) | HRH3KDM4ERECQLTDP1ALDH1A1 | |
| SCHEMBL26157408 | 1.00 | HRH3 (0.56) | HRH3KDM4ERECQLTDP1ALDH1A1 | |
| SCHEMBL20234909 | 0.98 | KDM4E (0.55) | HRH3KDM4ERECQLTDP1ALDH1A1 | |
| SCHEMBL20231628 | 0.93 | HRH3 (0.50) | HRH3KDM4ERECQLTDP1ALDH1A1 | |
| SCHEMBL12704907 | 0.92 | SIGMAR1 (0.54) | HRH3KDM4ERECQLTDP1ALDH1A1 | |
| SCHEMBL20234908 | 0.91 | KDM4E (0.49) | HRH3KDM4ERECQLTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023093728-A1 | BRM SELECTIVE DEGRADATION AGENT COMPOUND AND USE THEREOF | 江苏先声药业有限公司 | 2023-06-01 | — | — | WO | disclosed |